Kenneth M. Cohen

Kenneth M. Cohen appears in our data through filings on Mabvax Therapeutics Holdings, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 4 April 2016 to 2 April 2018, the count stands at 8 filings.

The open-market side counts 1 purchase alongside 2 sales for €25k. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 option exercises. 2018 to date brings no purchases and 2 sales.

The newest entry dates from 4 April 2018: an option exercise, in Mabvax Therapeutics Holdings, Inc. The latest purchase dates back some time: it was published 3,714 days ago, on 19 August 2016. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.